The current SNPX market cap is 89.98M. The company's latest EPS is USD -0.6757 and P/E is -6.53.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.17M | -5.89M | -2.92M | -1.83M | -1.43M |
Net Income | -3.03M | 4.37M | -1.98M | -10.21M | -362k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -15.51M | -11.16M | -12.62M | -16.14M | -8.31M |
Net Income | -15.14M | -15.13M | -12.61M | -5.69M | -13.78M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 27.35M | 38.61M | 36.53M | 33.44M | 32.36M |
Total Liabilities | 684k | 3.19M | 2.34M | 6.53M | 3.93M |
Total Equity | 26.67M | 32.69M | 31.46M | 24.83M | 26.74M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 17.9M | 6.75M | 35.53M | 38.61M | 31.11M |
Total Liabilities | 479k | 1.61M | 2M | 3.19M | 5.53M |
Total Equity | 17.42M | 5.14M | 33.53M | 32.69M | 24.35M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -8.43M | -11.21M | -1.7M | -2.94M | -4.11M |
Investing | -5k | -7k | -2k | -3k | -3k |
Financing | 553k | 14.48M | N/A | -1.64M | -1.64M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -11.89M | -8.1M | -8.71M | -11.21M | -5.17M |
Investing | -5k | -5k | -3k | -7k | -2M |
Financing | 420k | -3.48M | 37.13M | 14.48M | -1.64M |
Market Cap | 89.98M |
Price to Earnings Ratio | -6.53 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.14 |
Price to Book Ratio | 3.51 |
Dividend Yield | - |
Shares Outstanding | 20.39M |
Average Volume (1 week) | 36.08k |
Average Volume (1 Month) | 243.84k |
52 Week Change | -81.42% |
52 Week High | 47.00 |
52 Week Low | 3.5275 |
Spread (Intraday) | 0.44 (9.5%) |
Company Name | Synaptogenix Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.synaptogen.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.